Minal Mehta

Minal Mehta, Ph.D. has a diverse background in cell and molecular biology, with experience in leading clinical assays, bioanalytical and biomarker strategies, and translational research. Minal has held positions at Moderna and AstraZeneca, focusing on cardiovascular drug development programs targeting inflammation and fibrosis in heart failure. Additionally, Minal has experience as an academic tutor, science instructor, and Ph.D. candidate at the University of Pennsylvania School of Medicine.